4.6 Article

Disease Correction the iPSC Way: Advances in iPSC-Based Therapy

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 89, 期 5, 页码 746-749

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2010.341

关键词

-

资金

  1. G. Harold and Leila Y. Mathers Charitable Foundation
  2. Sanofi-Aventis
  3. MICINN
  4. Fundacion Cellex

向作者/读者索取更多资源

Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据